Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing

Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of gene...

Descripción completa

Detalles Bibliográficos
Autores: Rudilla, Francesc, Franco-Jarava, Clara|||0000-0002-9788-189X, Martínez Gallo, Mónica|||0000-0002-7340-2161, Garcia-Prat, Marina|||0000-0001-5387-1908, Martín-Nalda, Andrea|||0000-0002-1715-153X, Rivière, Jacques, Aguiló-Cucurull, Aina|||0000-0001-5622-778X, Mongay, Laura, Vidal, Francisco|||0000-0001-8089-4945, Solanich, Xavier|||0000-0002-2572-2187, Irastorza, Iñaki, Santos-Pérez, Juan Luis, Tercedor Sánchez, Jesús, Cusco, Ivon|||0000-0003-2104-9332, Serra, Clara, Baz-Redón, Noelia|||0000-0003-1704-3413, Fernández Cancio, Mónica|||0000-0003-1872-3488, Carreras, Carmen, Vagace, Manuel, García-Patos Briones, Vicente|||0000-0003-1654-6035, Pujol-Borrell, Ricardo|||0000-0001-7833-675X, Soler-Palacín, Pere|||0000-0002-0346-5570, Colobrán Oriol, Roger|||0000-0002-5964-536X
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:223391
Acceso en línea:https://ddd.uab.cat/record/223391
https://dx.doi.org/urn:doi:10.3389/fimmu.2019.02325
Access Level:acceso abierto
Palabra clave:Primary immunodeficiencies
Next generation sequencing
Clinical exome sequencing
TruSight one
Sequencing panel
Mutations
Genetic variants
id ES_699e466a0db7ed68c5f8385cdeb0a2a7
oai_identifier_str oai:ddd.uab.cat:223391
network_acronym_str ES
network_name_str España
repository_id_str
spelling Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome SequencingExpected and Unexpected FindingsRudilla, FrancescFranco-Jarava, Clara|||0000-0002-9788-189XMartínez Gallo, Mónica|||0000-0002-7340-2161Garcia-Prat, Marina|||0000-0001-5387-1908Martín-Nalda, Andrea|||0000-0002-1715-153XRivière, JacquesAguiló-Cucurull, Aina|||0000-0001-5622-778XMongay, LauraVidal, Francisco|||0000-0001-8089-4945Solanich, Xavier|||0000-0002-2572-2187Irastorza, IñakiSantos-Pérez, Juan LuisTercedor Sánchez, JesúsCusco, Ivon|||0000-0003-2104-9332Serra, ClaraBaz-Redón, Noelia|||0000-0003-1704-3413Fernández Cancio, Mónica|||0000-0003-1872-3488Carreras, CarmenVagace, ManuelGarcía-Patos Briones, Vicente|||0000-0003-1654-6035Pujol-Borrell, Ricardo|||0000-0001-7833-675XSoler-Palacín, Pere|||0000-0002-0346-5570Colobrán Oriol, Roger|||0000-0002-5964-536XPrimary immunodeficienciesNext generation sequencingClinical exome sequencingTruSight oneSequencing panelMutationsGenetic variantsPrimary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders.Universitat Autònoma de Barcelona 22019-01-0120192019-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/223391https://dx.doi.org/urn:doi:10.3389/fimmu.2019.02325reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengInstituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI14-00405Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI17-00660open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2233912026-06-06T12:50:31Z
dc.title.none.fl_str_mv Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
Expected and Unexpected Findings
title Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
spellingShingle Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
Rudilla, Francesc
Primary immunodeficiencies
Next generation sequencing
Clinical exome sequencing
TruSight one
Sequencing panel
Mutations
Genetic variants
title_short Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
title_full Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
title_fullStr Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
title_full_unstemmed Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
title_sort Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing
dc.creator.none.fl_str_mv Rudilla, Francesc
Franco-Jarava, Clara|||0000-0002-9788-189X
Martínez Gallo, Mónica|||0000-0002-7340-2161
Garcia-Prat, Marina|||0000-0001-5387-1908
Martín-Nalda, Andrea|||0000-0002-1715-153X
Rivière, Jacques
Aguiló-Cucurull, Aina|||0000-0001-5622-778X
Mongay, Laura
Vidal, Francisco|||0000-0001-8089-4945
Solanich, Xavier|||0000-0002-2572-2187
Irastorza, Iñaki
Santos-Pérez, Juan Luis
Tercedor Sánchez, Jesús
Cusco, Ivon|||0000-0003-2104-9332
Serra, Clara
Baz-Redón, Noelia|||0000-0003-1704-3413
Fernández Cancio, Mónica|||0000-0003-1872-3488
Carreras, Carmen
Vagace, Manuel
García-Patos Briones, Vicente|||0000-0003-1654-6035
Pujol-Borrell, Ricardo|||0000-0001-7833-675X
Soler-Palacín, Pere|||0000-0002-0346-5570
Colobrán Oriol, Roger|||0000-0002-5964-536X
author Rudilla, Francesc
author_facet Rudilla, Francesc
Franco-Jarava, Clara|||0000-0002-9788-189X
Martínez Gallo, Mónica|||0000-0002-7340-2161
Garcia-Prat, Marina|||0000-0001-5387-1908
Martín-Nalda, Andrea|||0000-0002-1715-153X
Rivière, Jacques
Aguiló-Cucurull, Aina|||0000-0001-5622-778X
Mongay, Laura
Vidal, Francisco|||0000-0001-8089-4945
Solanich, Xavier|||0000-0002-2572-2187
Irastorza, Iñaki
Santos-Pérez, Juan Luis
Tercedor Sánchez, Jesús
Cusco, Ivon|||0000-0003-2104-9332
Serra, Clara
Baz-Redón, Noelia|||0000-0003-1704-3413
Fernández Cancio, Mónica|||0000-0003-1872-3488
Carreras, Carmen
Vagace, Manuel
García-Patos Briones, Vicente|||0000-0003-1654-6035
Pujol-Borrell, Ricardo|||0000-0001-7833-675X
Soler-Palacín, Pere|||0000-0002-0346-5570
Colobrán Oriol, Roger|||0000-0002-5964-536X
author_role author
author2 Franco-Jarava, Clara|||0000-0002-9788-189X
Martínez Gallo, Mónica|||0000-0002-7340-2161
Garcia-Prat, Marina|||0000-0001-5387-1908
Martín-Nalda, Andrea|||0000-0002-1715-153X
Rivière, Jacques
Aguiló-Cucurull, Aina|||0000-0001-5622-778X
Mongay, Laura
Vidal, Francisco|||0000-0001-8089-4945
Solanich, Xavier|||0000-0002-2572-2187
Irastorza, Iñaki
Santos-Pérez, Juan Luis
Tercedor Sánchez, Jesús
Cusco, Ivon|||0000-0003-2104-9332
Serra, Clara
Baz-Redón, Noelia|||0000-0003-1704-3413
Fernández Cancio, Mónica|||0000-0003-1872-3488
Carreras, Carmen
Vagace, Manuel
García-Patos Briones, Vicente|||0000-0003-1654-6035
Pujol-Borrell, Ricardo|||0000-0001-7833-675X
Soler-Palacín, Pere|||0000-0002-0346-5570
Colobrán Oriol, Roger|||0000-0002-5964-536X
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv Primary immunodeficiencies
Next generation sequencing
Clinical exome sequencing
TruSight one
Sequencing panel
Mutations
Genetic variants
topic Primary immunodeficiencies
Next generation sequencing
Clinical exome sequencing
TruSight one
Sequencing panel
Mutations
Genetic variants
description Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders.
publishDate 2019
dc.date.none.fl_str_mv 2
2019-01-01
2019
2019-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/223391
https://dx.doi.org/urn:doi:10.3389/fimmu.2019.02325
url https://ddd.uab.cat/record/223391
https://dx.doi.org/urn:doi:10.3389/fimmu.2019.02325
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI14-00405
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI17-00660
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869410042714783744
score 15.300719